{
    "Trade/Device Name(s)": [
        "ELITech Clinical Systems CALCIUM ARSENAZO"
    ],
    "Submitter Information": "ELITech Clinical Systems SAS",
    "510(k) Number": "K151113",
    "Predicate Device Reference 510(k) Number(s)": [
        "K123171"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CJY"
    ],
    "Summary Letter Date": "April 23, 2015",
    "Summary Letter Received Date": "April 27, 2015",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1145"
    ],
    "Regulation Name(s)": [
        "Calcium test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Calcium"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma",
        "Urine"
    ],
    "Specimen Container(s)": [
        "Lithium heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "ELITech Clinical Systems Selectra Pro Series Analyzers",
        "Selectra Pro M Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Colorimetric test",
        "Arsenazo III complex formation"
    ],
    "Methodologies": [
        "Quantitative measurement",
        "Colorimetric determination"
    ],
    "Submission Type(s)": [
        "Kit",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for ELITech Clinical Systems CALCIUM ARSENAZO kit for quantitative determination of calcium in serum, plasma, and urine using Selectra Pro Series Analyzers",
    "Indications for Use Summary": "Quantitative in vitro diagnostic determination of total calcium in human serum, plasma, and urine to aid in the diagnosis and treatment of parathyroid disease, bone diseases, chronic renal disease, and tetany; for use with Selectra Pro Series Analyzers; not intended for point-of-care settings",
    "fda_folder": "Clinical Chemistry"
}